EDEN — Eden Research Share News
0.000.00%
- £20.80m
- £19.56m
- £4.30m
- 30
- 14
- 61
- 23
REG - Eden Research plc - Change of Registered Office
AnnouncementREG - Eden Research plc - Half-year Report
AnnouncementREG - Eden Research plc - New authorisations for Cedroz™ and Mevalone®
AnnouncementREG - Eden Research plc - Key patent granted for Eden’s Sustaine technology
AnnouncementREG - Eden Research plc - Regulatory approval for Cedroz™ in Spain
AnnouncementREG - Eden Research plc - New authorisation for bio-fungicide in Australia
AnnouncementREG - Eden Research plc - New authorisation for Cedroz™ in Greece
AnnouncementREG - Eden Research plc - Appointment of Global Head of Biology and Dev
AnnouncementRCS - Eden Research plc - New office and laboratory in Oxfordshire
AnnouncementREG - Eden Research plc - Patents granted in the United States
AnnouncementREG - Eden Research plc - Result of AGM
AnnouncementREG - Eden Research plc - Issuing of Annual Report & Notice of AGM
AnnouncementREG - Eden Research plc - Update on Bayer Animal Health Agreement
AnnouncementREG - Eden Research plc - New authorisations for Cedroz and Mevalone
AnnouncementREG - Eden Research plc - Financial Results for Year Ended 31 December 2019
AnnouncementREG - Eden Research plc - Notice of Results
AnnouncementREG - Eden Research plc - Appointment of Director of Regulatory Affairs
AnnouncementRCS - Eden Research plc - Organic farming certification in Italy and Spain
AnnouncementREG - Eden Research plc - Holding(s) in Company
Announcement